GAPVAC results presentation at ASCO 2018 (June 1-5) in Chicago, IL

Results from the GAPVAC clinical trial will be presented at ASCO 2018!

The oral presentation “GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma” by Lead Investigator Prof. Dr. Wolfgang Wick (University Hospital Heidelberg, Germany) will take place on June 1st during the Central Nervous System Tumors session (starting 2:45 pm CDT).

Visit www.asco.org for more information.